Public-registry trials using Elismetrep that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | Kallyope Inc. | Acute Migraine | PHASE3 | 120 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →